These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9816260

  • 1. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells.
    Marverti G, Andrews PA.
    Clin Cancer Res; 1996 Jun; 2(6):991-9. PubMed ID: 9816260
    [Abstract] [Full Text] [Related]

  • 2. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
    Andrews PA, Albright KD.
    Cancer Res; 1992 Apr 01; 52(7):1895-901. PubMed ID: 1551118
    [Abstract] [Full Text] [Related]

  • 3. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY, Rogers PM, Kelland LR.
    Clin Cancer Res; 1995 Sep 01; 1(9):981-9. PubMed ID: 9816070
    [Abstract] [Full Text] [Related]

  • 4. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
    Xuan Y, Hacker MP, Tritton TR, Bhushan A.
    Oncol Rep; 1998 Sep 01; 5(2):419-21. PubMed ID: 9468571
    [Abstract] [Full Text] [Related]

  • 5. Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance.
    Zinkewich-Péotti K, Andrews PA.
    Cancer Res; 1992 Apr 01; 52(7):1902-6. PubMed ID: 1551119
    [Abstract] [Full Text] [Related]

  • 6. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Andrews PA, Velury S, Mann SC, Howell SB.
    Cancer Res; 1988 Jan 01; 48(1):68-73. PubMed ID: 3335000
    [Abstract] [Full Text] [Related]

  • 7. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
    Jekunen A, Vick J, Sanga R, Chan TC, Howell SB.
    Cancer Res; 1992 Jul 01; 52(13):3566-71. PubMed ID: 1617625
    [Abstract] [Full Text] [Related]

  • 8. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.
    Andrews PA, Mann SC, Huynh HH, Albright KD.
    Cancer Res; 1991 Jul 15; 51(14):3677-81. PubMed ID: 1648442
    [Abstract] [Full Text] [Related]

  • 9. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
    Mann SC, Andrews PA, Howell SB.
    Anticancer Res; 1988 Jul 15; 8(6):1211-5. PubMed ID: 3218956
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
    Chau Q, Stewart DJ.
    Cancer Chemother Pharmacol; 1999 Jul 15; 44(3):193-202. PubMed ID: 10453720
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
    Lei W, Mayotte JE, Levitt ML.
    Anticancer Res; 1999 Jul 15; 19(1A):221-8. PubMed ID: 10226546
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G, Howell SB.
    Cancer Chemother Pharmacol; 2006 Jun 15; 57(6):781-8. PubMed ID: 16170571
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
    Reyes-Cruz G, Vázquez-Prado J, Müller-Esterl W, Vaca L.
    J Cell Biochem; 2000 Jan 15; 76(4):658-73. PubMed ID: 10653985
    [Abstract] [Full Text] [Related]

  • 14. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
    Waud WR.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6549-55. PubMed ID: 3677093
    [Abstract] [Full Text] [Related]

  • 15. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle.
    Cappelletti V, Fioravanti L, Miodini P, Di Fronzo G.
    J Cell Biochem; 2000 Sep 14; 79(4):594-600. PubMed ID: 10996850
    [Abstract] [Full Text] [Related]

  • 16. Secretin regulates paracellular permeability in canine gastric monolayers by a Src kinase-dependent pathway.
    Chen MC, Solomon TE, Perez Salazar E, Kui R, Rozengurt E, Soll AH.
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct 14; 283(4):G893-9. PubMed ID: 12223349
    [Abstract] [Full Text] [Related]

  • 17. Effect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).
    Jennerwein M, Andrews PA.
    Drug Metab Dispos; 1995 Feb 14; 23(2):178-84. PubMed ID: 7736908
    [Abstract] [Full Text] [Related]

  • 18. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F, Knobbe CB, Frank B, Wolburg H, Weller M.
    Oncol Rep; 2008 Apr 14; 19(4):1061-6. PubMed ID: 18357397
    [Abstract] [Full Text] [Related]

  • 19. Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
    Naredi P, Heath DD, Enns RE, Howell SB.
    Cancer Res; 1994 Dec 15; 54(24):6464-8. PubMed ID: 7987844
    [Abstract] [Full Text] [Related]

  • 20. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
    Melvik JE, Dornish JM, Larsen RO, Børretzen B, Oftebro R, Pettersen EO.
    Anticancer Res; 1992 Dec 15; 12(1):33-8. PubMed ID: 1567178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.